Dr. Hasenin Al-Khersan, MD
What this data tells you about Dr. Al-Khersan
Dr. Hasenin Al-Khersan is a retina specialist physician in Bellaire, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Al-Khersan performed 766 Medicare services across 562 unique beneficiaries.
Between the years covered by Open Payments, Dr. Al-Khersan received a total of $29,443 from 21 pharmaceutical and/or device companies across 112 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Al-Khersan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
173 | $31 | $127 |
| Aflibercept eye injection (Eylea) | 160 | $672 | $2,675 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
109 | $104 | $484 |
| Emergency department visit, low level of medical decision making An emergency department visit for a patient requiring a low level of medical decision making. |
89 | $55 | $250 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
85 | $96 | $396 |
| Ranibizumab-eqrn injection, 0.1 mg An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose. |
56 | $214 | $840 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
24 | $109 | $469 |
| Unclassified biologic A biologic product that does not have a specific HCPCS code assigned. |
22 | $2,120 | $8,111 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
20 | $28 | $116 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $124 | $521 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
11 | $104 | $394 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (77%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Al-Khersan is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 11% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Al-Khersan experienced with retinal imaging (oct scan)?
Does Dr. Al-Khersan receive payments from pharmaceutical companies?
How do Dr. Al-Khersan's costs compare to other retina specialist physicians in Bellaire?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology